PTO Won't Let Lipitor Patent Last Past 2010

The U.S. Patent and Trademark Office dealt Pfizer Inc. another blow Thursday in the company's ongoing fight to hang onto its patents to the world's best-selling drug, cholesterol treatment Lipitor, when...

Already a subscriber? Click here to view full article